# Design Therapeutics, Inc.: filings

DSGN · Nasdaq · CIK 1807120 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dsgn.md) · [Financials](/companies/dsgn/financials.md) · [Filings](/companies/dsgn/filings.md) · [Insiders](/companies/dsgn/insiders.md)

## Reports and events: 74 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 92, 8-K 38, 3 23, 10-Q 17, CORRESP 8, SC 13G 8, SC 13G/A 7, 144 6, S-8 6, 10-K 5, DEF 14A 5, DEFA14A 5, SCHEDULE 13G/A 5, ARS 4, UPLOAD 4, EFFECT 3, SCHEDULE 13D/A 3, SCHEDULE 13G 3, D 2, S-3 2, SC 13D 2, SC 13D/A 2, SEC STAFF LETTER 2, 3/A 1, 424B4 1, 4/A 1, 8-A12B 1, CERT 1, D/A 1, DEFR14A 1, DRS 1, S-1 1, S-1/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-03 | 08:07 ET | [10-Q](/filings/0001193125-26-329579.md) | Quarterly report, period 2026-06-30 | 0001193125-26-329579 |
| 2026-08-03 | 08:03 ET | [8-K](/filings/0001193125-26-329570.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-329570 |
| 2026-06-11 | 16:05 ET | [8-K](/filings/0001193125-26-267485.md) | 5.07 Shareholder vote results | 0001193125-26-267485 |
| 2026-05-18 | 07:15 ET | [8-K](/filings/0001193125-26-227875.md) | 8.01 Other events | 0001193125-26-227875 |
| 2026-04-28 | 16:13 ET | [10-Q](/filings/0001193125-26-187063.md) | Quarterly report, period 2026-03-31 | 0001193125-26-187063 |
| 2026-04-28 | 16:09 ET | [8-K](/filings/0001193125-26-187012.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0001193125-26-187012 |
| 2026-04-23 | 16:06 ET | [DEF 14A](/filings/0001193125-26-173678.md) | Proxy statement, period 2026-04-23 | 0001193125-26-173678 |
| 2026-04-01 | 16:03 ET | [8-K](/filings/0001193125-26-137861.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-137861 |
| 2026-03-11 | 21:28 ET | [SCHEDULE 13D/A](/filings/0001072613-26-000257.md) | Ownership report, active investor, amended | 0001072613-26-000257 |
| 2026-03-09 | 16:08 ET | [10-K](/filings/0001193125-26-098491.md) | Annual report, period 2025-12-31 | 0001193125-26-098491 |
| 2026-03-09 | 16:06 ET | [8-K](/filings/0001193125-26-098474.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-098474 |
| 2026-01-30 | 16:05 ET | [8-K](/filings/0001193125-26-031772.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-031772 |
| 2025-11-18 | 17:57 ET | [SCHEDULE 13D/A](/filings/0000935836-25-000710.md) | Ownership report, active investor, amended | 0000935836-25-000710 |
| 2025-11-12 | 17:10 ET | [SCHEDULE 13D/A](/filings/0000935836-25-000657.md) | Ownership report, active investor, amended | 0000935836-25-000657 |
| 2025-11-05 | 16:15 ET | [10-Q](/filings/0001193125-25-266970.md) | Quarterly report, period 2025-09-30 | 0001193125-25-266970 |
| 2025-11-05 | 16:10 ET | [8-K](/filings/0001193125-25-266933.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-266933 |
| 2025-09-10 | 16:04 ET | [8-K](/filings/0001807120-25-000004.md) | 5.02 Departure or appointment of officers or directors | 0001807120-25-000004 |
| 2025-08-07 | 16:18 ET | [10-Q](/filings/0000950170-25-105062.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105062 |
| 2025-08-07 | 16:08 ET | [8-K](/filings/0000950170-25-105008.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure | 0000950170-25-105008 |
| 2025-06-12 | 16:18 ET | [8-K](/filings/0000950170-25-085380.md) | 5.07 Shareholder vote results | 0000950170-25-085380 |
| 2025-05-07 | 16:07 ET | [10-Q](/filings/0000950170-25-065643.md) | Quarterly report, period 2025-03-31 | 0000950170-25-065643 |
| 2025-05-07 | 16:04 ET | [8-K](/filings/0000950170-25-065613.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065613 |
| 2025-04-24 | 16:05 ET | [DEF 14A](/filings/0000950170-25-058008.md) | Proxy statement, period 2025-06-10 | 0000950170-25-058008 |
| 2025-03-10 | 07:16 ET | [10-K](/filings/0000950170-25-035910.md) | Annual report, period 2024-12-31 | 0000950170-25-035910 |
| 2025-03-10 | 07:10 ET | [8-K](/filings/0000950170-25-035909.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-035909 |
| 2025-01-13 | 09:09 ET | [8-K](/filings/0000950170-25-004612.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-004612 |
| 2024-11-07 | 16:13 ET | [10-Q](/filings/0000950170-24-123349.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123349 |
| 2024-11-07 | 16:06 ET | [8-K](/filings/0000950170-24-123289.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-123289 |
| 2024-08-13 | 18:53 ET | [SC 13D/A](/filings/0000935836-24-000514.md) | Ownership report, active investor, amended | 0000935836-24-000514 |
| 2024-08-05 | 08:12 ET | [10-Q](/filings/0000950170-24-090337.md) | Quarterly report, period 2024-06-30 | 0000950170-24-090337 |
| 2024-08-05 | 08:01 ET | [8-K](/filings/0000950170-24-090332.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-090332 |
| 2024-06-17 | 16:12 ET | [8-K](/filings/0000950170-24-074243.md) | 5.07 Shareholder vote results | 0000950170-24-074243 |
| 2024-05-08 | 16:31 ET | [10-Q](/filings/0000950170-24-055788.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055788 |
| 2024-05-08 | 16:09 ET | [8-K](/filings/0000950170-24-055645.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055645 |
| 2024-04-25 | 16:30 ET | [DEF 14A](/filings/0000950170-24-048385.md) | Proxy statement, period 2024-06-13 | 0000950170-24-048385 |
| 2024-03-19 | 16:17 ET | [10-K](/filings/0000950170-24-033492.md) | Annual report, period 2023-12-31 | 0000950170-24-033492 |
| 2024-03-19 | 16:12 ET | [8-K](/filings/0000950170-24-033475.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-033475 |
| 2023-11-13 | 16:14 ET | [10-Q](/filings/0000950170-23-062958.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062958 |
| 2023-11-13 | 16:10 ET | [8-K](/filings/0000950170-23-062937.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062937 |
| 2023-08-25 | 17:01 ET | [8-K](/filings/0001193125-23-221586.md) | 5.02 Departure or appointment of officers or directors | 0001193125-23-221586 |
| 2023-08-14 | 16:11 ET | [10-Q](/filings/0000950170-23-042411.md) | Quarterly report, period 2023-06-30 | 0000950170-23-042411 |
| 2023-08-14 | 16:07 ET | [8-K](/filings/0000950170-23-042392.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-042392 |
| 2023-06-01 | 16:45 ET | [8-K](/filings/0001193125-23-159009.md) | 5.07 Shareholder vote results | 0001193125-23-159009 |
| 2023-05-09 | 16:20 ET | [10-Q](/filings/0000950170-23-019714.md) | Quarterly report, period 2023-03-31 | 0000950170-23-019714 |
| 2023-05-09 | 16:13 ET | [8-K](/filings/0000950170-23-019682.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-019682 |
| 2023-04-13 | 16:36 ET | [DEF 14A](/filings/0000950170-23-012723.md) | Proxy statement, period 2023-05-31 | 0000950170-23-012723 |
| 2023-03-14 | 16:13 ET | [10-K](/filings/0000950170-23-007869.md) | Annual report, period 2022-12-31 | 0000950170-23-007869 |
| 2023-03-14 | 16:07 ET | [8-K](/filings/0000950170-23-007864.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-007864 |
| 2022-12-22 | 16:25 ET | [SC 13D/A](/filings/0001193125-22-311061.md) | Ownership report, active investor, amended | 0001193125-22-311061 |
| 2022-11-03 | 16:16 ET | [10-Q](/filings/0000950170-22-021885.md) | Quarterly report, period 2022-09-30 | 0000950170-22-021885 |

Page 1 of 2. [Older](/companies/dsgn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.